Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...
Navigating the system to avoid tariffs on smaller orders is just too time-consuming or difficult for many entrepreneurs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results